269 related articles for article (PubMed ID: 19847609)
1. Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.
Hirano Y; Ito T; Nozaki M; Yasukawa T; Sakurai E; Yoshida M; Ogura Y
Jpn J Ophthalmol; 2009 Sep; 53(5):519-22. PubMed ID: 19847609
[TBL] [Abstract][Full Text] [Related]
2. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection.
Yamamoto Y; Komatsu T; Koura Y; Nishino K; Fukushima A; Ueno H
Can J Ophthalmol; 2008 Feb; 43(1):42-7. PubMed ID: 18204501
[TBL] [Abstract][Full Text] [Related]
3. Triamcinolone intravitreal injection and intraocular pressure in macular edema associated with retinal vein occlusion.
Wei Y; Wang HZ; Chen FH; Wang RS; Yang XG
Eye Sci; 2012 Dec; 27(4):182-7. PubMed ID: 23225839
[TBL] [Abstract][Full Text] [Related]
4. Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.
Aref AA; Scott IU; Oden NL; Ip MS; Blodi BA; VanVeldhuisen PC;
JAMA Ophthalmol; 2015 Sep; 133(9):1022-9. PubMed ID: 26086920
[TBL] [Abstract][Full Text] [Related]
5. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
[TBL] [Abstract][Full Text] [Related]
6. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
[TBL] [Abstract][Full Text] [Related]
7. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
[TBL] [Abstract][Full Text] [Related]
8. Incidence of increased intraocular pressure after subtenon injection of triamcinolone acetonide.
Kawamura R; Inoue M; Shinoda H; Shinoda K; Itoh Y; Ishida S; Tsubota K
J Ocul Pharmacol Ther; 2011 Jun; 27(3):299-304. PubMed ID: 21510808
[TBL] [Abstract][Full Text] [Related]
9. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
Inatani M; Iwao K; Kawaji T; Hirano Y; Ogura Y; Hirooka K; Shiraga F; Nakanishi Y; Yamamoto H; Negi A; Shimonagano Y; Sakamoto T; Shima C; Matsumura M; Tanihara H
Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153
[TBL] [Abstract][Full Text] [Related]
10. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection.
Iwao K; Inatani M; Kawaji T; Koga T; Mawatari Y; Tanihara H
J Glaucoma; 2007 Mar; 16(2):251-6. PubMed ID: 17473740
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of clinical outcomes of raised intraocular pressure following intravitreal triamcinolone acetonide injection.
Singh P; Krishnaprasad R; Ayachit G; Joshi S
Rom J Ophthalmol; 2024; 68(1):37-44. PubMed ID: 38617725
[No Abstract] [Full Text] [Related]
13. Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis.
Jea SY; Byon IS; Oum BS
Korean J Ophthalmol; 2006 Jun; 20(2):99-103. PubMed ID: 16892645
[TBL] [Abstract][Full Text] [Related]
14. Secondary ocular hypertension after intravitreal injection with 2 mg or 4 mg of triamcinolone in retinal vein occlusion.
Chuang LH; Yeung L; Wang NK; Chen HS; Ku WC; Lai CC
J Ocul Pharmacol Ther; 2010 Aug; 26(4):325-8. PubMed ID: 20653482
[TBL] [Abstract][Full Text] [Related]
15. Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases.
Wykrota AA; Abdin AD; Munteanu C; Löw U; Seitz B
Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3569-3579. PubMed ID: 37432451
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
17. Anterior Migration of Triamcinolone Acetonide after Posterior Subtenon Injection for Macular Edema Predisposes to Intraocular Pressure Elevation.
Yang YH; Hsu WC; Hsieh YT
Curr Eye Res; 2021 May; 46(5):689-693. PubMed ID: 32985270
[TBL] [Abstract][Full Text] [Related]
18. Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide.
Mahar PS; Memon AS
J Coll Physicians Surg Pak; 2012 Nov; 22(11):699-702. PubMed ID: 23146849
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intraocular pressure elevation after anterior versus posterior subtenon triamcinolone acetonide acetate injection: a retrospective study.
Liu X; Li Y; Zhang Y; Du W; Sun S; Lin B; Chen H; Cheng L
Retina; 2012 Oct; 32(9):1838-43. PubMed ID: 22487579
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intravitreal preservative-free triamcinolone versus posterior sub-tenon triamcinolone acetonide injection for bevacizumab-resistant diabetic macular edema.
Jeon SH; Kim M; Roh YJ
BMC Ophthalmol; 2024 Jan; 24(1):25. PubMed ID: 38243166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
